Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

Bladder cancer is the 10th most popular cancer in the world, and non-muscle-invasive bladder cancer (NMIBC) is diagnosed in ~80% of all cases. Treatments for NMIBC include transurethral resection of the bladder tumor (TURBT) and intravesical instillations of Bacillus Calmette-Guérin (BCG). Treatment...

Full description

Bibliographic Details
Main Authors: Maciej Jaromin, Tomasz Konecki, Piotr Kutwin
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
NMIBC
conservative treatment
BCG instillations
BCG-unresponsive
Adstiladrin
Pembrolizumab
Online Access:https://www.mdpi.com/2072-6694/16/7/1366

Internet

https://www.mdpi.com/2072-6694/16/7/1366

Similar Items